Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

NEUROMODEL

Financiado

Cerrado

Initial Training Network on therapeutic approaches and predictive models for neu...

Initial Training Network on therapeutic approaches and predictive models for neurodegenerative diseases Neurodegenerative diseases such as Parkinsonâ€™s disease (PD) and Huntingtonâ€™s disease (HD) still lack treatments that are disease modifying. The proposed network is going to address the three most important bottlenecks for find... ver más

14/10/2012

3M€

Presupuesto del proyecto: 3M€

Líder del proyecto

EBERHARD KARLS UNIVERSITAET TUEBINGEN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 10 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2012-10-14 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

10 Participantes

0.00€ | Lider

KU Leuven

N.D. | Participante

KINGS COLLEGE LONDON

N.D. | Participante

NOVARTIS

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PROTEASOME-AMYLOID Linking aggregation of alpha synuclein to proteasomal dysfun... 173K€ Cerrado

NeuronAgeScreen A Drug Discovery and Target Identification Screening Platfor... 150K€ Cerrado

NEUROFOLD Deciphering the molecular basis of neurodegenerative disease... 100K€ Cerrado

SAF2016-76520-R PAPEL DE NRF2 EN LA FUNCION Y EL DESTINO DEL CEREBRO CON ALZ... 411K€ Cerrado

TINTIN Training in neurodegeneration therapeutics intervention and... 4M€ Cerrado

CROSS-NEUROD Transferring autonomous and non autonomous cell degeneration... 693K€ Cerrado

Líder del proyecto

EBERHARD KARLS UNIVERSITAET TUEBINGEN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 3M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Neurodegenerative diseases such as Parkinsonâ€™s disease (PD) and Huntingtonâ€™s disease (HD) still lack treatments that are disease modifying. The proposed network is going to address the three most important bottlenecks for finding more effective medicine in brain disorders. Those are: (i) identification and validation of pre-symptomatic and surrogate marker for disease progression, (ii) Development of model systems that translate to human pathology and are predictive of clinical efficacy, and (iii) better understanding of disease mechanisms leading to better target selection. We believe that a joint effort putting together industry and academia offers a great opportunity to cope with those bottlenecks. Therefore, we have assembled a unique consortium to which industry (5 partners) and academia (5 partners) contribute equally. Through putting together these partners into one network Neuromodel is going to achieve both organization of an excellent training program and performance of excellent research projects with a pronounced focus on intersectional transfer of knowledge. The gain for individual early stage researchers as well as for the participating research teams is obvious. On the one hand, the career chances of young researchers will improve enormously by receiving high quality training (for and by research) in areas of high demand on the employment market. On the other hand, the intersectional, interconnected and integrated research effort pursued by Neuromodel will definitively contribute towards finding more effective treatments in PD and HD. Expertise available within the consortium has lead to the definition of four structural elements â€ (i) understanding disease mechanisms leading to target identification, (ii) approaches towards treatment, (iii) development of models predictive for efficacy and translating to human pathology, (iv) behavioural markers of animal models - that determines the training as well as the research program.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores